The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Asan Medical Center
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- To evaluate the effectiveness of biofeedback therapy in Parkinson's disease
Study Overview
Brief Summary
The aims of the investigators' study are to characterize the nature of constipation in idiopathic Parkinson's disease (IPD) and to evaluate the usefulness of biofeedback therapy in constipated IPD patients.
Detailed Description
The medical treatment of idiopathic Parkinson's disease (IPD) alleviates constipation symptoms due to the restoration of autonomic dysfunction. However, additional laxatives are usually needed in these patients. Other suppository treatments included stool softeners, dopamine-receptor agonists, botulinum toxins, and prokinetic medications such as tegaserod. Biofeedback therapy (BFT) has been the gold standard for functional constipation with dyssynergic defecation or rectal hyposensitivity. However, researchers have not tried to evaluate its usefulness in constipated IPD patients up to now. The aims of our study are to characterize the nature of constipation in IPD and to evaluate the usefulness of BFT in constipated IPD patients.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Idiopathic Parkinson's disease
Exclusion Criteria
- •Secondary Parkinson's disease
Arms & Interventions
biofeedback
Intervention: biofeedback therapy (Other)
Outcomes
Primary Outcomes
To evaluate the effectiveness of biofeedback therapy in Parkinson's disease
Time Frame: usually six sessions per one biofeedback for 3 months
Secondary Outcomes
- to evaluate the constipation type in Parkinson's disease(3-6 months)